Page last updated: 2024-08-24

3-iodobenzylguanidine and Atherosclerotic Parkinsonism

3-iodobenzylguanidine has been researched along with Atherosclerotic Parkinsonism in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buongiorno, MT; Compta, Y; Gaig, C; Lomeña, F; Martí, MJ; Muxi, A; Navarro-Otano, J; Tolosa, E; Valldeoriola, F1
Arita, H; Fujita, S; Futami, S; Kawai, K; Kiyohara, S; Nagamachi, S; Nakazato, M; Nishii, R; Tamura, S; Wakamatsu, H; Yamashita, S1
Kim, YJ; Lee, PH; Yeo, SH; Yong, SW1

Other Studies

3 other study(ies) available for 3-iodobenzylguanidine and Atherosclerotic Parkinsonism

ArticleYear
123I-MIBG cardiac uptake, smell identification and 123I-FP-CIT SPECT in the differential diagnosis between vascular parkinsonism and Parkinson's disease.
    Parkinsonism & related disorders, 2014, Volume: 20, Issue:2

    Topics: 3-Iodobenzylguanidine; Aged; Cross-Sectional Studies; Diagnosis, Differential; Female; Heart; Humans; Male; Parkinson Disease; Parkinson Disease, Secondary; Radiopharmaceuticals; Smell; Tomography, Emission-Computed, Single-Photon; Tropanes

2014
Usefulness of rCBF analysis in diagnosing Parkinson's disease: supplemental role with MIBG myocardial scintigraphy.
    Annals of nuclear medicine, 2008, Volume: 22, Issue:7

    Topics: 3-Iodobenzylguanidine; Aged; Cerebrovascular Circulation; Cross-Sectional Studies; Diagnosis, Differential; Female; Heart; Humans; Lewy Body Disease; Male; Middle Aged; Occipital Lobe; Parkinson Disease; Parkinson Disease, Secondary; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon

2008
Odour identification test and its relation to cardiac 123I-metaiodobenzylguanidine in patients with drug induced parkinsonism.
    Journal of neurology, neurosurgery, and psychiatry, 2007, Volume: 78, Issue:11

    Topics: 3-Iodobenzylguanidine; Aged; Diagnosis, Differential; Female; Follow-Up Studies; Heart; Humans; Male; Mediastinum; Middle Aged; Olfaction Disorders; Parkinson Disease, Secondary; Smell; Tomography, Emission-Computed, Single-Photon

2007